BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37871807)

  • 1. Cumulative incidence and timing of subsequent cutaneous squamous cell carcinomas stratified for patients with organ transplantation and hematologic malignancies: A nationwide cohort study.
    Eggermont CJ; Hollestein LM; Hollatz A; Louwman M; Mooyaart AL; Nijsten T; Wakkee M
    J Am Acad Dermatol; 2024 Mar; 90(3):530-536. PubMed ID: 37871807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
    Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
    JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative incidence and disease-specific survival of metastatic cutaneous squamous cell carcinoma: A nationwide cancer registry study.
    Tokez S; Wakkee M; Kan W; Venables ZC; Mooyaart AL; Louwman M; Nijsten T; Hollestein LM
    J Am Acad Dermatol; 2022 Feb; 86(2):331-338. PubMed ID: 34653569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
    Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
    J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989-2017.
    Tokez S; Wakkee M; Louwman M; Noels E; Nijsten T; Hollestein L
    JAMA Dermatol; 2020 Sep; 156(9):973-981. PubMed ID: 32609322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
    Levine DE; Karia PS; Schmults CD
    JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
    Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
    JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study.
    van Lee CB; Roorda BM; Wakkee M; Voorham Q; Mooyaart AL; de Vijlder HC; Nijsten T; van den Bos RR
    Br J Dermatol; 2019 Aug; 181(2):338-343. PubMed ID: 30199574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host and primary tumor factors for the development of multiple cutaneous squamous cell carcinomas among a retrospective cohort in Rhode Island.
    Moseley I; Ahmed F; Lin E; Lim R; Hoang M; Baranwal N; Robinson-Bostom L; Libby T; Wisco O; Qureshi A; Cho E
    J Am Acad Dermatol; 2023 Sep; 89(3):511-518. PubMed ID: 37011813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA expression as a risk factor for metastases of cutaneous squamous-cell carcinoma in organ- transplant recipients.
    de Jong E; Quint KD; El Ghalbzouri A; Verdijk RM; Goeman JJ; Heidt S; Claas FHJ; de Fijter JW; Genders RE; Vermeer MH; Bouwes Bavinck JN
    Hum Immunol; 2023 Mar; 84(3):208-213. PubMed ID: 36621381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cohort and nested case-control study of cutaneous squamous cell carcinoma in solid organ transplant recipients, by medication.
    Dusendang JR; Carlson E; Lee DS; Marwaha S; Madani S; Alexeeff SE; Webber A; Goes NB; Herrinton LJ
    J Am Acad Dermatol; 2022 Mar; 86(3):598-606. PubMed ID: 34384835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive and in situ squamous cell carcinoma of the skin: a nationwide study in Iceland.
    Adalsteinsson JA; Olafsdottir E; Ratner D; Waldman R; Feng H; Ungar J; Silverberg JI; Kristjansson AK; Jonasson JG; Tryggvadottir L
    Br J Dermatol; 2021 Sep; 185(3):537-547. PubMed ID: 33609287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study).
    Stenz NA; Stampf S; Arnold AW; Cozzio A; Dickenmann M; Gaide O; Harms M; Hunger RE; Laffitte E; Mühlstädt M; Nägeli M; Hofbauer GFL;
    Dermatology; 2021; 237(6):970-980. PubMed ID: 33227788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate and Characteristics of Incompletely Excised Cutaneous Squamous Cell Carcinoma: A Dermatological Daily Practice Multicenter Prospective Cohort Study.
    van Lee CB; Kouloubis N; Wakkee M; Kelleners-Smeets NWJ; Nellen RGL; van Rengen A; de Vijlder HC; Wijne LCC; Nijsten T; van den Bos RR
    Dermatol Surg; 2022 Dec; 48(12):1269-1273. PubMed ID: 36194767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of keratinocyte carcinomas after organ transplantation.
    Madeleine MM; Patel NS; Plasmeijer EI; Engels EA; Bouwes Bavinck JN; Toland AE; Green AC;
    Br J Dermatol; 2017 Nov; 177(5):1208-1216. PubMed ID: 28994104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England.
    Venables ZC; Autier P; Nijsten T; Wong KF; Langan SM; Rous B; Broggio J; Harwood C; Henson K; Proby CM; Rashbass J; Leigh IM
    JAMA Dermatol; 2019 Mar; 155(3):298-306. PubMed ID: 30484823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of advanced cutaneous squamous cell carcinoma.
    Dessinioti C; Pitoulias M; Stratigos AJ
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):39-50. PubMed ID: 34592000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation.
    Vos M; Plasmeijer EI; van Bemmel BC; van der Bij W; Klaver NS; Erasmus ME; de Bock GH; Verschuuren EAM; Rácz E
    J Heart Lung Transplant; 2018 Jul; 37(7):853-859. PubMed ID: 29680587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of cutaneous squamous cell carcinoma in a New Zealand population of chronic lymphocytic leukaemia patients.
    Hock BD; McIntosh ND; McKenzie JL; Pearson JF; Simcock JW; MacPherson SA
    Intern Med J; 2016 Dec; 46(12):1414-1421. PubMed ID: 27664975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
    Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
    Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.